BVMF/GEHC34 (BVMF/GEHC34)

Brazil Stock Exchange: BVMF/GEHC34 · BRL

R$49.0

+8.20 (+20.1%)· Recorded snapshot

Market cap	175.3B
Revenue (ttm)	112.1B
Net income (ttm)	11.2B
EPS (ttm)	R$3.15
P/E (trailing)	15.5x
P/E (forward)	13.4x
Dividend	R$0.06 (0.13%)
Volume	7

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 112.1B
Net income (ttm): 11.2B
EPS (ttm): R$3.15
P/E (trailing): 15.5x
P/E (forward): 13.4x
Market cap: 175.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E13.4

P25 n/aP50 n/aP75 n/a

Trailing P/E15.5

P25 n/aP50 n/aP75 n/a

ROE20

P25 n/aP50 n/aP75 n/a

ROIC13.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/GEHC34 indicators

Market & fundamental data

Available fields

225

Groups with data

Currency

USD

Showing 225 of 225 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-10-28
Employees	54,000
Employees change	1,000
Employees growth	1.89%
Enterprise value	BRL 221.8B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-10-10
Fiscal year end	December
Founded	2022
Industry	Medical Devices
Is primary listing	No
ISIN number	BRGEHCBDR009
Last earnings date	2026-10-28
Last refreshed	2026-10-28
Market cap	BRL 175.3B
Next earnings date	2026-10-28
Price	BRL 49.04
Price currency	BRL
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-26
Symbol	bvmf/GEHC34
Website	https://www.gehealthcare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	19.05x
Average P/E ratio (5Y)	19.17x
Earnings yield	6.43%
EV/Earnings	19.57x
EV/EBIT	12.79x
EV/EBITDA	10.53x
EV/FCF	22.31x
EV/Sales	1.89x
FCF / EV yield	4.48%
FCF yield	5.7%
Forward P/E	13.36x
Graham number	35.46021
Graham upside	-27.69%
Lynch fair value	BRL 15.92
Lynch upside	-67.53%
P/(FCF - SBC) ratio	19.09x
P/(OCF - SBC) ratio	14.65x
P/B ratio	2.79x
P/E ratio	15.54x
P/FCF ratio	17.55x
P/OCF ratio	13.73x
P/S ratio	1.53x
Price/EBITDA ratio	8.7x
Sector forward P/E	11.33x
Sector P/E	41.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	14.73%
EBITDA margin	17.61%
Effective tax rate	20.25%
FCF margin	8.48%
Gross margin	39.94%
Operating margin	14.73%
Pretax margin	12.81%
Profit margin	9.95%
Profit per employee	BRL 206,525
Profitable quarters	20
Profitable years	7
Revenue per employee	BRL 2.1M
ROA	5.35%
ROA (5Y)	5.96%
ROCE	10.79%
ROE	20.01%
ROE (5Y)	19.24%
ROIC	13.15%
ROIC (5Y)	13.87%
SBC / revenue	0.7%
Tax / revenue	2.59%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-2.07%
EPS growth (Q)	39.05%
EPS growth (QoQ)	9.82%
EPS growth 3Y	11.96%
EPS growth quarters	1
EPS growth years	2
FCF growth	34.93%
FCF growth (Q)	64.18%
FCF growth (QoQ)	1,066.18%
FCF growth 3Y	3.11%
FCF growth 5Y	5.43%
Gross profit growth	4.61%
Gross profit growth (Q)	11.81%
Gross profit growth 3Y	3.93%
Gross profit growth 5Y	5.01%
Net income growth	-2.84%
Net income growth (Q)	37.89%
Net income growth (QoQ)	9.63%
Net income growth 3Y	11.91%
Net income growth 5Y	-31.08%
Net income growth quarters	1
Net income growth years	2
OCF growth	30.54%
OCF growth (Q)	52.95%
OCF growth (QoQ)	439.88%
OCF growth 3Y	4.89%
OCF growth 5Y	7.44%
Operating income growth	12.25%
Operating income growth (Q)	9.99%
Operating income growth 3Y	4.19%
Operating income growth 5Y	3.26%
Revenue growth	6.87%
Revenue growth (Q)	7.19%
Revenue growth (QoQ)	4.12%
Revenue growth 3Y	3.91%
Revenue growth 5Y	4.74%
Revenue growth quarters	9
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -2.7B
Depreciation and amortization	BRL 3.3B
EBIT	BRL 16.5B
EBITDA	BRL 19.7B
EPS	BRL 3.15
Financing cash flow	BRL -2.8B
Free cash flow	BRL 9.8B
Free cash flow minus SBC	BRL 9B
Gross profit	BRL 44.8B
Income taxes	BRL 2.9B
Investing cash flow	BRL -15.5B
Net borrowing	BRL -661.6M
Net cash flow	BRL -6.1B
Net income	BRL 11.2B
Operating cash flow minus SBC	BRL 11.7B
Operating income	BRL 16.5B
Revenue	BRL 112.1B
Stock-based compensation	BRL 787.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	BRL 133.06
Debt / EBITDA	2.57
Debt / equity	0.84
Debt / FCF	5.28
Goodwill	BRL 80.8B
Interest coverage	8.37
Long-term assets	BRL 137.4B
Long-term liabilities	BRL 90.3B
Net cash (debt)	BRL -36.9B
Net cash / market cap	-21.47%
Net debt / EBITDA	1.87
Net debt / equity	0.6
Net debt / FCF	3.77
Piotroski F-Score	6
Property, plant and equipment	BRL 17.2B
Shareholders' equity	BRL 61.5B
Tangible book value	BRL -27.7B
Tangible book value per share	BRL -61.15
Total assets	BRL 198.8B
Total cash	BRL 14.8B
Total debt	BRL 51.7B
Total liabilities	BRL 137.3B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.58
Current assets	BRL 61.3B
Current liabilities	BRL 47B
Current ratio	1.3
Inventory turnover	5.27
Net working capital	BRL -885.8M
Quick ratio	0.77
Working capital	BRL 13.9B
Working capital turnover	49.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.55%
Dividend growth	-3.19%
Dividend growth years	1
Dividend payment date	2026-11-19
Dividend payment years	3
Dividend payout frequency	Quarterly
Dividend per share	BRL 0.06
Dividend yield	0.13%
Ex-dividend date	2026-10-22
Last dividend	BRL 0.02
Payout ratio	2.97%
Shareholder yield	0.67%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	20.08%
1M price change	13.01%
1M total return	13.05%
1W price change	-0%
1W total return	-0%
1Y price change	8.61%
1Y return CAGR	8.82%
1Y total return	8.81%
20-day SMA	BRL 42.49
3M price change	26.51%
3M total return	26.62%
50-day SMA	BRL 45.45
52-week high	BRL 60.61
52-week high date	2026-01-05
52-week low	BRL 37.98
52-week low date	2026-07-21
6M price change	5.14%
6M total return	5.26%
All-time high	BRL 64.08
All-time high date	2024-11-01
All-time low	BRL 37.98
All-time low date	2026-07-21
Average true range (ATR)	BRL 2.08
Average volume	125.9
Change from 52-week high	-19.09%
Change from 52-week low	29.12%
Change from all-time high	-25.02%
Change from all-time low	26.51%
Change from open	5.12%
Day's gap	14.23%
Dollar volume	BRL 343
High price	BRL 49.04
Low price	BRL 46.65
Monthly RSI	42.91
Open price	BRL 46.65
Position in 52-week range	100%
Previous close	BRL 40.84
Price vs 20-day SMA	13.09%
Price vs 50-day SMA	5.73%
Relative volume	0.06
RSI	58.82
Sharpe ratio	-0.34
Sortino ratio	-0.43
Volume	7
Weekly RSI	42.71
YTD price change	-3.92%
YTD total return	-3.78%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	450.2M
Shares change (QoQ)	-0.22%
Shares change (YoY)	-0.55%
Shares held by insiders	0.22%
Shares held by institutions	93.83%

Deeper analysis on BVMF/GEHC34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/GEHC34 report

Is a complete BVMF/GEHC34 research report available?

No complete published report is available for bvmf/GEHC34 (BVMF/GEHC34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/GEHC34 (BVMF/GEHC34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/GEHC34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/GEHC34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/GEHC34

Frequently asked questions